
BluePill Case study | FlavCity
The Goal
01
MaxDiff Claim Prioritization (Best-Worst Scaling)
BluePill ran a full MaxDiff study across 15 RTB claims — the same methodology used by top CPG insights teams. Each of BluePill's 100 AI Consumer Twins evaluated claim subsets, selecting the most and least appealing options in forced trade-offs, producing a ratio-scaled hierarchy where the brand could see exactly how much more motivating one claim was versus another.
02
Tier Structure & Strategic Claim Mapping
BluePill surfaced a clear three-tier structure: Tier 1 "Must-Have" claims, Tier 2 "Nice-to-Have" differentiators, and Tier 3 actively rejected claims. Each claim was mapped to a strategic category — giving FlavCity a ready-to-deploy messaging framework.
03
Head-to-Head Validation Against Human Panel
The same 15 claims were tested with a traditional human consumer panel using identical MaxDiff methodology. BluePill then compared AI vs. human results claim-by-claim — validating rank correlation, top/bottom alignment, and strategic decision equivalence. The result: both panels would produce the same brand brief, the same messaging hierarchy, and the same creative direction.
Time to insights.
Match to real human data
Investments.
Average Accuracy
Rank Order Alignment
Speed
Cost
Specific claims matter way more than others
Consumers preferred 1 claim 1.5× more than all the rest.
AI twins can replicate same brand brief in minutes
AI Twins produce same outcome in minutes vs. weeks for human panel
Strategic decisions don't change
Despite the outlier, both panels yielded the same strategy: same winners, losers, and brief.
Conclusion
BluePill used AI Consumer Twins to build a data-driven messaging hierarchy for FlavCity, achieving a high correlation with human panels. The study matched top and bottom claims exactly, delivering weeks of traditional MaxDiff rigor in just minutes.